<ul>
  <li>
    FormotÃ©rol + bÃ©clomÃ©tasone<br>
    <span class="text-black-secondary">Traitement de rÃ©fÃ©rence de lâ€™asthme de lâ€™adulte; autorisÃ© chez lâ€™enfant scolarisÃ© ğŸ§’.</span>
    <ul>
      <li>
        BÃ©clomÃ©tasone/formotÃ©rol <a href="https://bdpm.ansm.sante.fr/medicament/64896432/extrait#tab-rcp" rel="external nofollow noopener">100/6</a><br>
        NÃ©cessite coordination main-inspiration.
      </li>
      <li>
        Formodual ou Innovair <a href="https://bdpm.ansm.sante.fr/medicament/60130062/extrait#tab-rcp" rel="external nofollow noopener">100/6</a> ou <a href="https://bdpm.ansm.sante.fr/medicament/68340034/extrait#tab-rcp" rel="external nofollow noopener">200/6 Âµg</a><br>
        NÃ©cessite coordination main-inspiration.
      </li>
      <li>Formodual ou Innovair Nexthaler <a href="https://bdpm.ansm.sante.fr/medicament/63389629/extrait#tab-rcp" rel="external nofollow noopener">100/6</a> ou <a href="https://bdpm.ansm.sante.fr/medicament/64495254/extrait#tab-rcp" rel="external nofollow noopener">200/6 Âµg</a></li>
    </ul>
  </li>
  <li>
    <mark>FormotÃ©rol + budÃ©sonide</mark><br>
    <span class="text-black-secondary">Traitement de rÃ©fÃ©rence de lâ€™asthme; autorisÃ© chez lâ€™enfant scolarisÃ© ğŸ§’.</span>
    <ul>
      <li>
        Symbicort Rapihaler <a href="https://bdpm.ansm.sante.fr/medicament/65082080/extrait#tab-rcp" rel="external nofollow noopener">100/3 Âµg</a> et <a href="https://bdpm.ansm.sante.fr/medicament/66057945/extrait#tab-rcp" rel="external nofollow noopener">200/6 Âµg</a><br>
        NÃ©cessite coordination main-inspiration.
      </li>
      <li>Duoresp Spiromax <a href="https://ec.europa.eu/health/documents/community-register/2020/20200713148441/anx_148441_fr.pdf" rel="external nofollow noopener">160/4,5 Âµg</a> ou <a href="https://ec.europa.eu/health/documents/community-register/2020/20200713148441/anx_148441_fr.pdf" rel="external nofollow noopener">320/9 Âµg</a></li>
      <li>Gibiter Easyhaler <a href="https://bdpm.ansm.sante.fr/medicament/64579414/extrait#tab-rcp" rel="external nofollow noopener">160/4,5</a> ou <a href="https://bdpm.ansm.sante.fr/medicament/65441590/extrait#tab-rcp" rel="external nofollow noopener">320/9 Âµg</a></li>
      <li>Symbicort Turbuhaler <a href="https://bdpm.ansm.sante.fr/medicament/67916395/extrait#tab-rcp" rel="external nofollow noopener">100/6</a>, <a href="https://bdpm.ansm.sante.fr/medicament/61237448/extrait#tab-rcp" rel="external nofollow noopener">200/6</a> ou <a href="https://bdpm.ansm.sante.fr/medicament/64275087/extrait#tab-rcp" rel="external nofollow noopener">400/12 Âµg</a></li>
      <li>Ã‚ge: doses faibles | moyennes | Ã©levÃ©es (en Âµg/j)</li>
      <li>Asthme 6-11 ans: 100-200 | 200-400 | 400-800</li>
    </ul>
  </li>
  <li>
    IndacatÃ©rol + momÃ©tasone<br>
    Atectura Breezhaler <a href="https://ec.europa.eu/health/documents/community-register/2020/20200530148013/anx_148013_fr.pdf" rel="external nofollow noopener">125/62,5</a>, 125/127,5 et 125/260 Âµg
  </li>
  <li>
    SalmÃ©tÃ©rol + fluticasone<br>
    <span class="text-black-secondary">Traitement de rÃ©fÃ©rence de la BPCO selon <em>Prescrire</em>; autorisÃ© chez lâ€™enfant scolarisÃ© ğŸ§’.</span>
    <ul>
      <li>Seretide Diskus <a href="https://bdpm.ansm.sante.fr/medicament/67546191/extrait#tab-rcp" rel="external nofollow noopener">100/50</a>, <a href="https://bdpm.ansm.sante.fr/medicament/61572165/extrait#tab-rcp" rel="external nofollow noopener">250/50</a> ou <a href="https://bdpm.ansm.sante.fr/medicament/60569419/extrait#tab-rcp" rel="external nofollow noopener">500/50 Âµg</a></li>
      <li>Ã‚ge: doses faibles | moyennes | Ã©levÃ©es (en Âµg/j)</li>
      <li>Asthme 6-11 ans: 50-100 | 100-250 | 250-500</li>
    </ul>
  </li>
  <li>
    VilantÃ©rol + fluticasone
    <ul>
      <li>Relvar Ellipta <a href="https://www.ema.europa.eu/fr/documents/product-information/relvar-ellipta-epar-product-information_fr.pdf" rel="external nofollow noopener">92/22</a> ou <a href="https://www.ema.europa.eu/fr/documents/product-information/relvar-ellipta-epar-product-information_fr.pdf" rel="external nofollow noopener">184/22 Âµg</a></li>
      <li>Revinty Ellipta <a href="https://www.ema.europa.eu/fr/documents/product-information/revinty-ellipta-epar-product-information_fr.pdf" rel="external nofollow noopener">92/22</a> ou <a href="https://www.ema.europa.eu/fr/documents/product-information/revinty-ellipta-epar-product-information_fr.pdf" rel="external nofollow noopener">184/22 Âµg</a></li>
    </ul>
  </li>
</ul>
<hr class="my-3">
<p class="text-black-secondary">Rincer la bouche aprÃ¨s inhalation.</p>
<p class="text-black-secondary">Des inhalateurs sÃ©parÃ©s de LABA et CSI peuvent Ãªtre utilisÃ©s pour la bÃ©clomÃ©tasone ou le budÃ©sonide (privilÃ©gier la chambre dâ€™inhalation).</p>
<hr class="my-3">
<p>Ã‰lÃ©ments de la balance bÃ©nÃ©fice-risque des CSI: asthme, exacerbations frÃ©quentes, pneumonies, Ã©osinophilie.</p>